Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE PRENTICE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1912423773
CMS profile
2923303
Location
MASSENA, NY

General Payments · PY2018–2024

$431.54

  • Reported across 14 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$215.80

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $215.80 11

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $102.48 5
Novo Nordisk AS $42.89 2
Lilly USA, LLC $33.73 2
Amgen Inc. $19.02 1
GlaxoSmithKline, LLC. $17.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $124.99 1
PY2023 $90.75 2
PY2024 $215.80 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $19.02 02/08/2024 Food and Beverage Undisputed 01/23/2026 1117658900 CMS
AstraZeneca Pharmaceuticals LP $13.10 03/01/2024 Food and Beverage Undisputed 01/23/2026 1105560290 CMS
AstraZeneca Pharmaceuticals LP $27.19 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105706156 CMS
AstraZeneca Pharmaceuticals LP $13.30 03/19/2024 Food and Beverage Undisputed 01/23/2026 1105900616 CMS
AstraZeneca Pharmaceuticals LP $16.61 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104412699 CMS
AstraZeneca Pharmaceuticals LP $32.28 09/17/2024 Food and Beverage Undisputed 01/23/2026 1105734783 CMS
GlaxoSmithKline, LLC. $17.68 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116571133 CMS
Lilly USA, LLC $17.37 01/26/2024 Food and Beverage Undisputed 01/23/2026 1135173454 CMS
Lilly USA, LLC $16.36 02/05/2024 Food and Beverage Undisputed 01/23/2026 1135206481 CMS
Novo Nordisk Inc $23.23 01/24/2024 Food and Beverage Undisputed 01/23/2026 1097830548 CMS
Novo Nordisk Inc $19.66 02/20/2024 Food and Beverage Undisputed 01/23/2026 1096966388 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.